- Home
- / Tenax Therapeutics
- / Operating Metrics
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Tenax Therapeutics key operating metrics including Phase III Trials Products, environmental, and social and governance score (ESG).
Phase III Trials Products
1
FY, 2016
Patents Issued
7
FY, 2016
Pre-Clinical Phase Products
1
FY, 2016
Operating Metrics
Environmental, Social and Governance (ESG)
Overall
40-49 out of 100
Community
Employees
Environment
Governance
Premium Content only available in Craft’s Intelligence Portal
Learn moreSource:CSRHub